2015
DOI: 10.1016/j.cyto.2015.07.013
|View full text |Cite
|
Sign up to set email alerts
|

Cigarette smoke affects IL-17A, IL-17F and IL-17 receptor expression in the lung tissue: Ex vivo and in vitro studies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

3
26
1

Year Published

2016
2016
2024
2024

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 42 publications
(30 citation statements)
references
References 39 publications
(40 reference statements)
3
26
1
Order By: Relevance
“…Moreover, CS also influences DC function by altering their capability to produce prostaglandin-E2, IL-8, and IL-10, as well as suppressing the release of IL-12 and IL-23 (41). While CSE has been shown to increase expression of IL-17A and IL-17 receptor in the lung tissue (19) and certain individuals with chronic CS exposure have increased Th17 immunity (42), our data show that direct CSE exposure is not leading to Th17 polarization. This was shown by a reversed ability of Th CSE cells to produce IL-17 and IL-2.…”
Section: Discussioncontrasting
confidence: 49%
See 1 more Smart Citation
“…Moreover, CS also influences DC function by altering their capability to produce prostaglandin-E2, IL-8, and IL-10, as well as suppressing the release of IL-12 and IL-23 (41). While CSE has been shown to increase expression of IL-17A and IL-17 receptor in the lung tissue (19) and certain individuals with chronic CS exposure have increased Th17 immunity (42), our data show that direct CSE exposure is not leading to Th17 polarization. This was shown by a reversed ability of Th CSE cells to produce IL-17 and IL-2.…”
Section: Discussioncontrasting
confidence: 49%
“…Components of CS and CSE contain a large number of chemicals, many of which have cancerogenic properties (18) and trigger AhR signaling in the cells. Although AhR stimulation is directly involved in the development of Th17 and CS has been shown to increase IL-17A and IL-17F expression in lungs, little is known about the direct effect of CS components on the development of Th17 cells (3, 19). To address this, we tested the effect of CSE on Th17 cell polarization upon stimulation of the TCR/CD3 complex and in the presence of standard cytokines used for Th17 differentiation (20).…”
Section: Resultsmentioning
confidence: 99%
“…And, melanocyte apoptosis is considered as a mechanism of depigmentation in vitiligo (Singh et al, 2016). In many in vitro experiments, IL-17F possesses the pro-inflammatory function, similar to IL-17A, contributing to host defense and autoimmune function of Th17 cells (Jie et al, 2014;Montalbano et al, 2015), indicating that IL-17F may play similar roles as IL-17A in vitiligo. In many in vitro experiments, IL-17F possesses the pro-inflammatory function, similar to IL-17A, contributing to host defense and autoimmune function of Th17 cells (Jie et al, 2014;Montalbano et al, 2015), indicating that IL-17F may play similar roles as IL-17A in vitiligo.…”
Section: Discussionmentioning
confidence: 99%
“…Besides, IL-17F, as a newly discovered member of IL-17 family, shares high homology with IL-17A (Chang & Dong, 2009). In many in vitro experiments, IL-17F possesses the pro-inflammatory function, similar to IL-17A, contributing to host defense and autoimmune function of Th17 cells (Jie et al, 2014;Montalbano et al, 2015), indicating that IL-17F may play similar roles as IL-17A in vitiligo. Moreover, the mRNA levels of RORgt and BATF in PBMC were also detected to be dramatically increased in PBMC of vitiligo patients in our research.…”
Section: Discussionmentioning
confidence: 99%
“…Clinical studies have also demonstrated an inverse correlation between increased frequencies of IL-17-producing cells or serum IL-17 levels and favorable patient prognosis (5)(6)(7). In addition, a strong link between smoking, enhanced innate inflammatory activity, and IL-17 production has been reported in both preclinical and clinical studies (8)(9)(10). Therefore, therapeutic strategies that are designed to block IL-17driven inflammation could represent an attractive strategy for the prevention and/or treatment of early-stage lung cancer.…”
mentioning
confidence: 95%